{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:07:31Z","timestamp":1794002851708,"version":"4.8.0"},"reference-count":179,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1038\/s41579-021-00518-7","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T07:04:18Z","timestamp":1614150258000},"page":"467-480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":242,"title":["Toxoplasma gondii infection and its implications within the central nervous system"],"prefix":"10.1038","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2449-0916","authenticated-orcid":false,"given":"Sumit K.","family":"Matta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Rinkenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildiko R.","family":"Dunay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7110-0285","authenticated-orcid":false,"given":"L. David","family":"Sibley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"key":"518_CR1","unstructured":"Dubey, J. P. Toxoplasmosis of animals and humans (CRC, 2010)."},{"key":"518_CR2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/COH.0b013e32835211e9","volume":"7","author":"G Andreani","year":"2012","unstructured":"Andreani, G., Lodge, R., Richard, D. & Tremblay, M. J. Mechanisms of interaction between protozoan parasites and HIV. Curr. Opin. HIV AIDS 7, 276\u2013282 (2012).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"518_CR3","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00057-17","volume":"31","author":"IR Dunay","year":"2018","unstructured":"Dunay, I. R., Gajurel, K., Dhakal, R., Liesenfeld, O. & Montoya, J. G. Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice. Clin. Microbiol. Rev. 31, e00057-17 (2018).","journal-title":"Clin. Microbiol. Rev."},{"key":"518_CR4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias, L. C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5, 375\u2013386 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"518_CR5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008097","volume":"15","author":"D Fisch","year":"2019","unstructured":"Fisch, D., Clough, B. & Frickel, E. M. Human immunity to Toxoplasma gondii. PLoS Pathog. 15, e1008097 (2019).","journal-title":"PLoS Pathog."},{"key":"518_CR6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrmicro2858","volume":"10","author":"CA Hunter","year":"2012","unstructured":"Hunter, C. A. & Sibley, L. D. Modulation of innate immunity by Toxoplasma gondii virulence effectors. Nat. Rev. Microbiol. 10, 766\u2013778 (2012).","journal-title":"Nat. Rev. Microbiol."},{"key":"518_CR7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1128\/CMR.00005-17","volume":"30","author":"MA Hakimi","year":"2017","unstructured":"Hakimi, M. A., Olias, P. & Sibley, L. D. Toxoplasma effectors targeting host signaling and transcription. Clin. Microbiol. Rev. 30, 615\u2013645 (2017).","journal-title":"Clin. Microbiol. Rev."},{"key":"518_CR8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-micro-091014-104353","volume":"70","author":"MS Behnke","year":"2016","unstructured":"Behnke, M. S., Dubey, J. P. & Sibley, L. D. Genetic mapping of pathogenesis determinants in Toxoplasma gondii. Annu. Rev. Microbiol. 70, 63\u201381 (2016).","journal-title":"Annu. Rev. Microbiol."},{"key":"518_CR9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1017\/S0031182013001844","volume":"141","author":"EK Shwab","year":"2014","unstructured":"Shwab, E. K. et al. Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping. Parasitology 141, 453\u2013461 (2014).","journal-title":"Parasitology"},{"key":"518_CR10","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10147","volume":"7","author":"H Lorenzi","year":"2016","unstructured":"Lorenzi, H. et al. Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomes. Nat. Commun. 7, 10147 (2016).","journal-title":"Nat. Commun."},{"key":"518_CR11","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00281-012-0339-3","volume":"34","author":"CD Dupont","year":"2012","unstructured":"Dupont, C. D., Christian, D. A. & Hunter, C. A. Immune response and immunopathology during toxoplasmosis. Semin. Immunopathol. 34, 793\u2013813 (2012).","journal-title":"Semin. Immunopathol."},{"key":"518_CR12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nri3598","volume":"14","author":"F Yarovinsky","year":"2014","unstructured":"Yarovinsky, F. Innate immunity to Toxoplasma gondii infection. Nat. Rev. Immunol. 14, 109\u2013121 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"518_CR13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.immuni.2011.08.008","volume":"35","author":"M Mashayekhi","year":"2011","unstructured":"Mashayekhi, M. et al. CD8\u03b1+ dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity 35, 249\u2013259 (2011).","journal-title":"Immunity"},{"key":"518_CR14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.immuni.2012.09.016","volume":"38","author":"AA Koblansky","year":"2013","unstructured":"Koblansky, A. A. et al. Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii. Immunity 38, 119\u2013130 (2013).","journal-title":"Immunity"},{"key":"518_CR15","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.1109893","volume":"308","author":"F Yarovinsky","year":"2005","unstructured":"Yarovinsky, F. et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308, 1626\u20131629 (2005).","journal-title":"Science"},{"key":"518_CR16","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.immuni.2012.03.026","volume":"36","author":"RS Goldszmid","year":"2012","unstructured":"Goldszmid, R. S. et al. NK cell-derived interferon-\u03b3 orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity 36, 1047\u20131059 (2012).","journal-title":"Immunity"},{"key":"518_CR17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41590-018-0250-8","volume":"20","author":"A Safronova","year":"2019","unstructured":"Safronova, A. et al. Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii. Nat. Immunol. 20, 64\u201372 (2019).","journal-title":"Nat. Immunol."},{"key":"518_CR18","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/jlb.66.5.698","volume":"66","author":"WA Muller","year":"1999","unstructured":"Muller, W. A. & Randolph, G. J. Migration of leukocyytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. J. Leukoc. Biol. 66, 698\u2013704 (1999).","journal-title":"J. Leukoc. Biol."},{"key":"518_CR19","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.immuni.2008.05.019","volume":"29","author":"IR Dunay","year":"2008","unstructured":"Dunay, I. R. et al. Gr1+ inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity 29, 306\u2013317 (2008).","journal-title":"Immunity"},{"key":"518_CR20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.pt.2019.08.005","volume":"35","author":"A Tsitsiklis","year":"2019","unstructured":"Tsitsiklis, A., Bangs, D. J. & Robey, E. A. CD8+ T cell responses to Toxoplasma gondii: lessons from a successful parasite. Trends Parasitol. 35, 887\u2013898 (2019).","journal-title":"Trends Parasitol."},{"key":"518_CR21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1590\/S0074-02762009000200015","volume":"104","author":"M Schreiner","year":"2009","unstructured":"Schreiner, M. & Liesenfeld, O. Small intestinal inflammation following oral infection with Toxoplasma gondii does not occur exclusively in C57BL\/6 mice: review of 70 reports from the literature. Mem. Inst. Oswaldo Cruz 104, 221\u2013233 (2009).","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"518_CR22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/icb.2011.93","volume":"90","author":"CE Egan","year":"2012","unstructured":"Egan, C. E., Cohen, S. B. & Denkers, E. Y. Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger. Immunol. Cell Biol. 90, 668\u2013675 (2012).","journal-title":"Immunol. Cell Biol."},{"key":"518_CR23","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1084\/jem.20090900","volume":"206","author":"M Munoz","year":"2009","unstructured":"Munoz, M. et al. Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J. Exp. Med. 206, 3047\u20133059 (2009).","journal-title":"J. Exp. Med."},{"key":"518_CR24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ni.2508","volume":"14","author":"M Raetz","year":"2013","unstructured":"Raetz, M. et al. Parasite-induced TH1 cells and intestinal dysbiosis cooperate in IFN-\u03b3-dependent elimination of Paneth cells. Nat. Immunol. 14, 136\u2013142 (2013).","journal-title":"Nat. Immunol."},{"key":"518_CR25","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.4049\/jimmunol.177.12.8785","volume":"177","author":"MM Heimesaat","year":"2006","unstructured":"Heimesaat, M. M. et al. Gram-negative bacteria aggravate murine small intestinal TH1-type immunopathology following oral infection with Toxoplasma gondii. J. Immunol. 177, 8785\u20138795 (2006).","journal-title":"J. Immunol."},{"key":"518_CR26","volume":"10","author":"S Wang","year":"2019","unstructured":"Wang, S. et al. Infection-induced intestinal dysbiosis is mediated by macrophage activation and nitrate production. mBio 10, e00935 (2019).","journal-title":"mBio"},{"key":"518_CR27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009125","volume":"5","author":"C Erridge","year":"2010","unstructured":"Erridge, C., Duncan, S. H., Bereswill, S. & Heimesaat, M. M. The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5. PLoS ONE 5, e9125 (2010).","journal-title":"PLoS ONE"},{"key":"518_CR28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41583-018-0070-8","volume":"19","author":"JV Forrester","year":"2018","unstructured":"Forrester, J. V., McMenamin, P. G. & Dando, S. J. CNS infection and immune privilege. Nat. Rev. Neurosci. 19, 655\u2013671 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"518_CR29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fimmu.2019.00242","volume":"10","author":"D Schluter","year":"2019","unstructured":"Schluter, D. & Barragan, A. Advances and challenges in understanding cerebral toxoplasmosis. Front. Immunol. 10, 242 (2019).","journal-title":"Front. Immunol."},{"key":"518_CR30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood-2005-02-0666","volume":"107","author":"N Courret","year":"2005","unstructured":"Courret, N. et al. CD11c and CD11b expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 107, 309\u2013316 (2005). This early study demonstrates that monocytes are the infected cells found in blood following oral infection and that they seed the brain early in infection.","journal-title":"Blood"},{"key":"518_CR31","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1038\/s41564-019-0504-8","volume":"4","author":"LL Drewry","year":"2019","unstructured":"Drewry, L. L. et al. The secreted kinase ROP17 promotes Toxoplasma gondii dissemination by hijacking monocyte tissue migration. Nat. Microbiol. 4, 1951\u20131963 (2019). This paper shows that infection of monocytes by tachyzoites of T. gondii activates migration through interstitial tissues and suppresses trans-epithelial migration, thus questioning the role of the Trojan horse model of barrier transversal.","journal-title":"Nat. Microbiol."},{"key":"518_CR32","doi-asserted-by":"crossref","first-page":"16001","DOI":"10.1038\/nmicrobiol.2016.1","volume":"1","author":"C Konradt","year":"2016","unstructured":"Konradt, C. et al. Endothelial cells are a replicative niche for entry of Toxoplasma gondii to the central nervous system. Nat. Microbiol. 1, 16001 (2016). This paper shows that growth within endothelial cells lining the BBB leads to dispersal into the parenchyma when the host cell ruptures, providing an alternative entry route into the CNS.","journal-title":"Nat. Microbiol."},{"key":"518_CR33","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01155-15","volume":"6","author":"E Watts","year":"2015","unstructured":"Watts, E. et al. Novel approaches reveal that Toxoplasma gondii bradyzoites within tissue cysts are dynamic and replicating entities in vivo. mBio 6, e01155-15 (2015). This paper shows that bradyzoites are not dormant cells but, rather, replicate sporadically and asynchronously, albeit much slower than tachyzoites.","journal-title":"mBio"},{"key":"518_CR34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005447","volume":"12","author":"CM Cabral","year":"2016","unstructured":"Cabral, C. M. et al. Neurons are the primary target cell for the brain-tropic intracellular parasite Toxoplasma gondii. PLoS Pathog. 12, e1005447 (2016). This paper shows imaging of infected cells using Cre-reporter mice and parasites that secrete Cre during invasion and reveals that the primary cells infected in the mouse brain are neurons.","journal-title":"PLoS Pathog."},{"key":"518_CR35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002825","volume":"8","author":"AA Koshy","year":"2012","unstructured":"Koshy, A. A. et al. Toxoplasma co-opts host cells it does not invade. PLoS Pathog. 8, e1002825 (2012).","journal-title":"PLoS Pathog."},{"key":"518_CR36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrmicro1800","volume":"6","author":"JC Boothroyd","year":"2008","unstructured":"Boothroyd, J. C. & Dubremetz, J. F. Kiss and spit: the dual roles of Toxoplasma rhoptries. Nat. Rev. Microbiol. 6, 79\u201388 (2008).","journal-title":"Nat. Rev. Microbiol."},{"key":"518_CR37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/expr.1999.4421","volume":"93","author":"CG Luder","year":"1999","unstructured":"Luder, C. G., Giraldo-Velasquez, M., Sendtner, M. & Gross, U. Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation. Exp. Parasitol. 93, 23\u201332 (1999).","journal-title":"Exp. Parasitol."},{"key":"518_CR38","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/00005072-199611000-00006","volume":"55","author":"SK Halonen","year":"1996","unstructured":"Halonen, S. K., Lyman, W. D. & Chiu, F. C. Growth and development of Toxoplasma gondii in human neurons and astrocytes. J. Neuropathol. Exp. Neurol. 55, 1150\u20131156 (1996).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"518_CR39","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s00018-018-2808-x","volume":"75","author":"V Jeffers","year":"2018","unstructured":"Jeffers, V., Tampaki, Z., Kim, K. & Sullivan, W. J. Jr. A latent ability to persist: differentiation in Toxoplasma gondii. Cell. Mol. Life Sci. 75, 2355\u20132373 (2018).","journal-title":"Cell. Mol. Life Sci."},{"key":"518_CR40","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1126\/science.1078035","volume":"299","author":"C Su","year":"2003","unstructured":"Su, C. et al. Recent expansion of Toxoplasma through enhanced oral transmission. Science 299, 414\u2013416 (2003).","journal-title":"Science"},{"key":"518_CR41","volume":"2","author":"DP Hong","year":"2017","unstructured":"Hong, D. P., Radke, J. B. & White, M. W. Opposing transcriptional mechanisms regulate Toxoplasma development. mSphere 2, e00347-16 (2017).","journal-title":"mSphere"},{"key":"518_CR42","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/mmi.12121","volume":"87","author":"R Walker","year":"2013","unstructured":"Walker, R. et al. The Toxoplasma nuclear factor TgAP2XI-4 controls bradyzoite gene expression and cyst formation. Mol. Microbiol. 87, 641\u2013655 (2013).","journal-title":"Mol. Microbiol."},{"key":"518_CR43","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1073\/pnas.1300059110","volume":"110","author":"JB Radke","year":"2013","unstructured":"Radke, J. B. et al. ApiAP2 transcription factor restricts development of the Toxoplasma tissue cyst. Proc. Natl Acad. Sci. USA 110, 6871\u20136876 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"518_CR44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007035","volume":"14","author":"JB Radke","year":"2018","unstructured":"Radke, J. B. et al. Transcriptional repression by ApiAP2 factors is central to chronic toxoplasmosis. PLoS Pathog. 14, e1007035 (2018).","journal-title":"PLoS Pathog."},{"key":"518_CR45","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cell.2019.12.013","volume":"180","author":"BS Waldman","year":"2020","unstructured":"Waldman, B. S. et al. Identification of a master regulator of differentiation in Toxoplasma. Cell 180, 359\u2013372 e16 (2020). This genome-wide CRISPR screening identifies a Myb-like transcription regulatory that is both necessary and sufficient to drive bradyzoite development in T. gondii.","journal-title":"Cell"},{"key":"518_CR46","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1084\/jem.20082826","volume":"206","author":"A Bougdour","year":"2009","unstructured":"Bougdour, A. et al. Drug inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites. J. Exp. Med. 206, 953\u2013966 (2009).","journal-title":"J. Exp. Med."},{"key":"518_CR47","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41564-020-0674-4","volume":"5","author":"DC Farhat","year":"2020","unstructured":"Farhat, D. C. et al. A MORC-driven transcriptional switch controls Toxoplasma developmental trajectories and sexual commitment. Nat. Microbiol. 5, 570\u2013583 (2020). This paper shows that a MORC orthologue in T. gondii acts as a transcriptional repressor acts together with AP2 transcription factors and HDAC3 to suppress sexual phase development and promote the asexual phases of the life cycle.","journal-title":"Nat. Microbiol."},{"key":"518_CR48","doi-asserted-by":"crossref","first-page":"102030","DOI":"10.1016\/j.parint.2019.102030","volume":"76","author":"Y Suzuki","year":"2020","unstructured":"Suzuki, Y. The immune system utilizes two distinct effector mechanisms of T cells depending on two different life cycle stages of a single pathogen, Toxoplasma gondii, to control its cerebral infection. Parasitol. Int. 76, 102030 (2020).","journal-title":"Parasitol. Int."},{"key":"518_CR49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fcimb.2019.00073","volume":"9","author":"AK Bhandage","year":"2019","unstructured":"Bhandage, A. K., Kanatani, S. & Barragan, A. Toxoplasma-induced hypermigration of primary cortical microglia implicates GABAergic signaling. Front. Cell. Infect. Microbiol. 9, 73 (2019).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"518_CR50","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17491-z","volume":"11","author":"SJ Batista","year":"2020","unstructured":"Batista, S. J. et al. Gasdermin-D-dependent IL-1\u03b1 release from microglia promotes protective immunity during chronic Toxoplasma gondii infection. Nat. Commun. 11, 3687 (2020).","journal-title":"Nat. Commun."},{"key":"518_CR51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002246","volume":"7","author":"B John","year":"2011","unstructured":"John, B. et al. Analysis of behavior and trafficking of dendritic cells within the brain during toxoplasmic encephalitis. PLoS Pathog. 7, e1002246 (2011).","journal-title":"PLoS Pathog."},{"key":"518_CR52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000505","volume":"5","author":"B John","year":"2009","unstructured":"John, B. et al. Dynamic imaging of CD8+ T cells and dendritic cells during infection with Toxoplasma gondii. PLoS Pathog 5, e1000505 (2009).","journal-title":"PLoS Pathog"},{"key":"518_CR53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fcimb.2017.00259","volume":"7","author":"A Biswas","year":"2017","unstructured":"Biswas, A. et al. Behavior of neutrophil granulocytes during Toxoplasma gondii infection in the central nervous system. Front. Cell. Infect. Microbiol. 7, 259 (2017).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"518_CR54","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4049\/jimmunol.149.1.175","volume":"149","author":"R Gazzinelli","year":"1992","unstructured":"Gazzinelli, R., Xu, Y., Hieny, S., Cheever, A. & Sher, A. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J. Immunol. 149, 175\u2013180 (1992).","journal-title":"J. Immunol."},{"key":"518_CR55","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.4049\/jimmunol.1402037","volume":"194","author":"A Biswas","year":"2015","unstructured":"Biswas, A. et al. Ly6Chigh monocytes control cerebral toxoplasmosis. J. Immunol. 194, 3223\u20133235 (2015).","journal-title":"J. Immunol."},{"key":"518_CR56","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2353\/ajpath.2008.080129","volume":"173","author":"L Benevides","year":"2008","unstructured":"Benevides, L., Milanezi, C. M., Yamauchi, L. M., Silva, J. S. & Silva, N. M. CCR2 receptor is essential to activate microbicdal mechanisms to control Toxoplasma gondii infection in the central nervous system. Am. J. Path 173, 741\u2013751 (2008). Together with Biswas et al. (2015), this paper shows that inflammatory monocytes are recruited to the CNS, where they are essential in the control of T. gondii infection.","journal-title":"Am. J. Path"},{"key":"518_CR57","doi-asserted-by":"crossref","first-page":"24796","DOI":"10.1073\/pnas.1915778116","volume":"116","author":"CA Schneider","year":"2019","unstructured":"Schneider, C. A. et al. Imaging the dynamic recruitment of monocytes to the blood\u2013brain barrier and specific brain regions during Toxoplasma gondii infection. Proc. Natl Acad. Sci. USA 116, 24796\u201324807 (2019). This article, using in vivo imaging techniques, demonstrates that monocytes migrate to the brain of infected mice in response to clusters of replicating parasites in a highly regionalized manner.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"518_CR58","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.4049\/jimmunol.164.9.4826","volume":"164","author":"HG Fischer","year":"2000","unstructured":"Fischer, H. G., Bonifas, U. & Reichmann, G. Phenotype and functions of brain dendritic cells emerging during chronic infection of mice with Toxoplasma gondii. J. Immunol. 164, 4826\u20134834 (2000).","journal-title":"J. Immunol."},{"key":"518_CR59","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2353\/ajpath.2010.090825","volume":"176","author":"Y Suzuki","year":"2010","unstructured":"Suzuki, Y. et al. Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells. Am. J. Pathol. 176, 1607\u20131613 (2010).","journal-title":"Am. J. Pathol."},{"key":"518_CR60","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1016\/j.celrep.2019.05.051","volume":"27","author":"A Salvioni","year":"2019","unstructured":"Salvioni, A. et al. Robust control of a brain-persisting parasite through MHC I presentation by infected neurons. Cell Rep. 27, 3254\u20133268 e8 (2019). Although neurons are often thought to express low levels of MHC molecules, this study demonstrates an important role for MHC class I in neurons of the CNS in controlling toxoplasmosis in the mouse.","journal-title":"Cell Rep."},{"key":"518_CR61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002393","volume":"7","author":"G Chevalier","year":"2011","unstructured":"Chevalier, G. et al. Neurons are MHC class I-dependent targets for CD8 T cells upon neurotropic viral infection. PLoS Pathog. 7, e1002393 (2011).","journal-title":"PLoS Pathog."},{"key":"518_CR62","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.4049\/jimmunol.143.6.2045","volume":"143","author":"Y Suzuki","year":"1989","unstructured":"Suzuki, Y., Conley, F. K. & Remington, J. S. Importance of endogenous IFN-\u03b3 for prevention of toxoplasmic encephalitis in mice. J. Immunol. 143, 2045\u20132050 (1989).","journal-title":"J. Immunol."},{"key":"518_CR63","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1128\/IAI.66.10.4989-4993.1998","volume":"66","author":"SK Halonen","year":"1998","unstructured":"Halonen, S. K., Chiu, F.-C. & Weiss, L. M. Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes. Infect. Immun. 66, 4989\u20134993 (1998).","journal-title":"Infect. Immun."},{"key":"518_CR64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s004300050031","volume":"185","author":"W D\u00e4ubener","year":"1997","unstructured":"D\u00e4ubener, W. & Hadding, U. Cellular immune reactions directed against Toxoplasma gondii with special emphasis on the central nervous system. Med. Microbiol. Immunol. 185, 195\u2013206 (1997).","journal-title":"Med. Microbiol. Immunol."},{"key":"518_CR65","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1128\/IAI.69.12.7889-7893.2001","volume":"69","author":"D Schluter","year":"2001","unstructured":"Schluter, D., Deckert, M., Hof, H. & Frei, K. Toxoplasma gondii infection of neurons induces neuronal cytokine and chemokine production, but interferon-\u03b3- and tumor necrosis factor-stimulated neurons fail to inhibit the invasion and growth of T. gondii. Infect. Immun. 69, 7889\u20137893 (2001).","journal-title":"Infect. Immun."},{"key":"518_CR66","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrn.2016.140","volume":"17","author":"KD Miller","year":"2016","unstructured":"Miller, K. D., Schnell, M. J. & Rall, G. F. Keeping it in check: chronic viral infection and antiviral immunity in the brain. Nat. Rev. Neurosci. 17, 766\u2013776 (2016).","journal-title":"Nat. Rev. Neurosci."},{"key":"518_CR67","doi-asserted-by":"crossref","first-page":"17480","DOI":"10.1073\/pnas.1904637116","volume":"116","author":"SK Matta","year":"2019","unstructured":"Matta, S. K. et al. Toxoplasma gondii effector TgIST blocks type I interferon signaling to promote infection. Proc. Natl Acad. Sci. USA 116, 17480\u201317491 (2019). This paper shows that type II interferon is the major mediator of resistance to T. gondii in the mouse, yet in the absence of type I interferon, mice are unable to control chronic infection, indicating that control of infection in the CNS relies on both pathways.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"518_CR68","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/icb.2014.70","volume":"92","author":"SJ Han","year":"2014","unstructured":"Han, S. J. et al. Internalization and TLR-dependent type I interferon production by monocytes in response to Toxoplasma gondii. Immunol. Cell Biol. 92, 872\u2013881 (2014).","journal-title":"Immunol. Cell Biol."},{"key":"518_CR69","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-virology-092818-015756","volume":"6","author":"JW Schoggins","year":"2019","unstructured":"Schoggins, J. W. Interferon-stimulated genes: what do they all do? Annu. Rev. Virol. 6, 567\u2013584 (2019).","journal-title":"Annu. Rev. Virol."},{"key":"518_CR70","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab, F., Mayer-Barber, K., Sher, A., Wack, A. & O\u2019Garra, A. Type I interferons in infectious disease. Nat. Rev. Immunol. 15, 87\u2013103 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"518_CR71","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","volume":"18","author":"LB Ivashkiv","year":"2018","unstructured":"Ivashkiv, L. B. IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat. Rev. Immunol. 18, 545\u2013558 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"518_CR72","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pneurobio.2017.05.003","volume":"156","author":"S Monteiro","year":"2017","unstructured":"Monteiro, S., Roque, S., Marques, F., Correia-Neves, M. & Cerqueira, J. J. Brain interference: revisiting the role of IFN\u03b3 in the central nervous system. Prog. Neurobiol. 156, 149\u2013163 (2017).","journal-title":"Prog. Neurobiol."},{"key":"518_CR73","doi-asserted-by":"crossref","first-page":"8719","DOI":"10.4049\/jimmunol.181.12.8719","volume":"181","author":"JA Portillo","year":"2008","unstructured":"Portillo, J. A. et al. CD40 mediates retinal inflammation and neurovascular degeneration. J. Immunol. 181, 8719\u20138726 (2008). This study indicates an important role for CD40 and activation of autophagy in endothelial cells as a mechanism to limit entry of T. gondii into the CNS.","journal-title":"J. Immunol."},{"key":"518_CR74","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4049\/jimmunol.1303284","volume":"193","author":"E Cekanaviciute","year":"2014","unstructured":"Cekanaviciute, E. et al. Astrocytic TGF-\u03b2 signaling limits inflammation and reduces neuronal damage during central nervous system Toxoplasma infection. J. Immunol. 193, 139\u2013149 (2014).","journal-title":"J. Immunol."},{"key":"518_CR75","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ajpath.2012.03.029","volume":"181","author":"U Handel","year":"2012","unstructured":"Handel, U. et al. Neuronal gp130 expression is crucial to prevent neuronal loss, hyperinflammation, and lethal course of murine Toxoplasma encephalitis. Am. J. Pathol. 181, 163\u2013173 (2012).","journal-title":"Am. J. Pathol."},{"key":"518_CR76","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/pim.12157","volume":"37","author":"A Parlog","year":"2015","unstructured":"Parlog, A., Schluter, D. & Dunay, I. R. Toxoplasma gondii-induced neuronal alterations. Parasite Immunol. 37, 159\u2013170 (2015).","journal-title":"Parasite Immunol."},{"key":"518_CR77","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/glia.23816","volume":"68","author":"GL Carrillo","year":"2020","unstructured":"Carrillo, G. L. et al. Toxoplasma infection induces microglia\u2013neuron contact and the loss of perisomatic inhibitory synapses. Glia 68, 1968\u20131986 (2020).","journal-title":"Glia"},{"key":"518_CR78","first-page":"459","volume":"7","author":"A Parlog","year":"2014","unstructured":"Parlog, A. et al. Chronic murine toxoplasmosis is defined by subtle changes in neuronal connectivity. Dis. Model Mech. 7, 459\u2013469 (2014).","journal-title":"Dis. Model Mech."},{"key":"518_CR79","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1242-1","volume":"15","author":"D Lang","year":"2018","unstructured":"Lang, D. et al. Chronic Toxoplasma infection is associated with distinct alterations in the synaptic protein composition. J. Neuroinflammation 15, 216 (2018). This paper shows that chronic infection with T. gondii results in impaired neuronal function as shown by loss of synaptic protein composition due to neuroinflammation.","journal-title":"J. Neuroinflammation"},{"key":"518_CR80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005643","volume":"12","author":"CN David","year":"2016","unstructured":"David, C. N. et al. GLT-1-dependent disruption of CNS glutamate homeostasis and neuronal function by the protozoan parasite Toxoplasma gondii. PLoS Pathog. 12, e1005643 (2016). This paper shows that disruption of glutamate regulation results in reduction of dendritic spines and compromises neuronal function.","journal-title":"PLoS Pathog."},{"key":"518_CR81","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.celrep.2019.12.019","volume":"30","author":"M Boillat","year":"2020","unstructured":"Boillat, M. et al. Neuroinflammation-associated aspecific manipulation of mouse predator fear by Toxoplasma gondii. Cell Rep. 30, 320\u2013334 e6 (2020). This paper shows that the parasite cyst load in the CNS is positively correlated with increased inflammation and altered behaviour, including loss of fear, in chronically infected mice.","journal-title":"Cell Rep."},{"key":"518_CR82","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02164-19","volume":"11","author":"HJ Johnson","year":"2020","unstructured":"Johnson, H. J. & Koshy, A. A. Latent toxoplasmosis effects on rodents and humans: how much is real and how much is media hype? mBio 11, e02164-19 (2020). This review nicely summarizes the literature on the controversial topic of how T. gondii infection influences neuronal function and behaviour.","journal-title":"mBio"},{"key":"518_CR83","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40478-016-0293-8","volume":"4","author":"L Mohle","year":"2016","unstructured":"Mohle, L. et al. Chronic Toxoplasma gondii infection enhances \u03b2-amyloid phagocytosis and clearance by recruited monocytes. Acta Neuropathol. Commun. 4, 25 (2016).","journal-title":"Acta Neuropathol. Commun."},{"key":"518_CR84","volume":"7","author":"BK Jung","year":"2012","unstructured":"Jung, B. K. et al. Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of Alzheimer\u2019s disease. PLoS ONE 7, e33312 (2012).","journal-title":"PLoS ONE"},{"key":"518_CR85","doi-asserted-by":"crossref","first-page":"175909141772491","DOI":"10.1177\/1759091417724915","volume":"9","author":"CM Cabral","year":"2017","unstructured":"Cabral, C. M., McGovern, K. E., MacDonald, W. R., Franco, J. & Koshy, A. A. Dissecting amyloid \u03b2 deposition using distinct strains of the neurotropic parasite Toxoplasma gondii as a novel tool. ASN Neuro 9, 1759091417724915 (2017).","journal-title":"ASN Neuro"},{"key":"518_CR86","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/jm301297f","volume":"56","author":"L Di","year":"2013","unstructured":"Di, L., Rong, H. & Feng, B. Demystifying brain penetration in central nervous system drug discovery. Miniperspective. J. Med. Chem. 56, 2\u201312 (2013).","journal-title":"J. Med. Chem."},{"key":"518_CR87","doi-asserted-by":"crossref","first-page":"15936","DOI":"10.1073\/pnas.1208069109","volume":"109","author":"JS Doggett","year":"2012","unstructured":"Doggett, J. S. et al. Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis. Proc. Natl Acad. Sci. USA 109, 15936\u201315941 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"518_CR88","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00535-20","volume":"64","author":"JS Doggett","year":"2020","unstructured":"Doggett, J. S. et al. Orally bioavailable endochin-like quinolone carbonate ester prodrug reduces Toxoplasma gondii brain cysts. Antimicrob. Agents Chemother. 64, e00535-20 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"518_CR89","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3389\/fcimb.2020.00203","volume":"10","author":"MJ McPhillie","year":"2020","unstructured":"McPhillie, M. J. et al. Potent tetrahydroquinolone eliminates apicomplexan parasites. Front. Cell Infect. Microbiol. 10, 203 (2020).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"518_CR90","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1128\/AAC.01683-15","volume":"59","author":"I Benmerzouga","year":"2015","unstructured":"Benmerzouga, I. et al. Guanabenz repurposed as an antiparasitic with activity against acute and latent toxoplasmosis. Antimicrob. Agents Chemother. 59, 6939\u20136945 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"518_CR91","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1128\/AAC.01823-13","volume":"58","author":"JS Doggett","year":"2014","unstructured":"Doggett, J. S., Ojo, K. K., Fan, E., Maly, D. J. & Van Voorhis, W. C. Bumped kinase inhibitor 1294 treats established Toxoplasma gondii infection. Antimicrob. Agents Chemother. 58, 3547\u20133549 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"518_CR92","doi-asserted-by":"crossref","first-page":"9976","DOI":"10.1021\/acs.jmedchem.7b01192","volume":"60","author":"FU Rutaganira","year":"2017","unstructured":"Rutaganira, F. U. et al. Inhibition of calcium dependent protein kinase 1 (CDPK1) by pyrazolopyrimidine analogs decreases establishment and reoccurrence of central nervous system disease by Toxoplasma gondii. J. Med. Chem. 60, 9976\u20139989 (2017).","journal-title":"J. Med. Chem."},{"key":"518_CR93","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1021\/acs.jmedchem.0c00419","volume":"63","author":"JW Janetka","year":"2020","unstructured":"Janetka, J. W. et al. Optimizing pyrazolopyrimidine inhibitors of calcium dependent protein kinase 1 for treatment of acute and chronic toxoplasmosis. J. Med. Chem. 63, 6144\u20136163 (2020).","journal-title":"J. Med. Chem."},{"key":"518_CR94","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2015.12.032","volume":"164","author":"S Mostafavi","year":"2016","unstructured":"Mostafavi, S. et al. Parsing the interferon transcriptional network and its disease associations. Cell 164, 564\u2013578 (2016).","journal-title":"Cell"},{"key":"518_CR95","doi-asserted-by":"crossref","first-page":"D1040","DOI":"10.1093\/nar\/gks1215","volume":"41","author":"I Rusinova","year":"2013","unstructured":"Rusinova, I. et al. Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res. 41, D1040\u2013D1046 (2013).","journal-title":"Nucleic Acids Res."},{"key":"518_CR96","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1128\/IAI.72.3.1257-1264.2004","volume":"72","author":"LC Gavrilescu","year":"2004","unstructured":"Gavrilescu, L. C., Butcher, B. A., Del Rio, L., Taylor, G. A. & Denkers, E. Y. STAT1 is essential for antimicrobial effector function but dispensable for \u03b3 interferon production during Toxoplasma gondii infection. Infect. Immun. 72, 1257\u20131264 (2004).","journal-title":"Infect. Immun."},{"key":"518_CR97","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4049\/jimmunol.172.1.457","volume":"172","author":"LA Lieberman","year":"2004","unstructured":"Lieberman, L. A., Banica, M., Reiner, S. L. & Hunter, C. A. STAT1 plays a critical role in the regulation of antimicrobial effector mechanisms, but not in the development of TH1-type responses during toxoplasmosis. J. Immunol. 172, 457\u2013463 (2004).","journal-title":"J. Immunol."},{"key":"518_CR98","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01881-16","volume":"7","author":"S Hidano","year":"2016","unstructured":"Hidano, S. et al. STAT1 signaling in astrocytes is essential for control of infection in the central nervous system. mBio 7, e01881-16 (2016). This study shows that STAT1 is required for IFN\u03b3 signalling and demonstrates the importance of this pathway in astrocytes for controlling infection in the brain.","journal-title":"mBio"},{"key":"518_CR99","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41564-020-0701-5","volume":"5","author":"ME Abrams","year":"2020","unstructured":"Abrams, M. E. et al. Oxysterols provide innate immunity to bacterial infection by mobilizing cell surface accessible cholesterol. Nat. Microbiol. 5, 929\u2013942 (2020).","journal-title":"Nat. Microbiol."},{"key":"518_CR100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006102","volume":"12","author":"SS Perelman","year":"2016","unstructured":"Perelman, S. S. et al. Cell-based screen identifies human interferon-stimulated regulators of Listeria monocytogenes infection. PLoS Pathog. 12, e1006102 (2016).","journal-title":"PLoS Pathog."},{"key":"518_CR101","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52130-8","volume":"9","author":"KJ Helbig","year":"2019","unstructured":"Helbig, K. J. et al. The interferon stimulated gene viperin, restricts Shigella flexneri in vitro. Sci Rep. 9, 15598 (2019).","journal-title":"Sci Rep."},{"key":"518_CR102","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4049\/jimmunol.1701322","volume":"201","author":"A Napolitano","year":"2018","unstructured":"Napolitano, A. et al. Cysteine-reactive free ISG15 generates IL-1\u03b2-producing CD8\u03b1+ dendritic cells at the site of infection. J. Immunol. 201, 604\u2013614 (2018).","journal-title":"J. Immunol."},{"key":"518_CR103","first-page":"492","volume":"5","author":"CS Meira","year":"2014","unstructured":"Meira, C. S. et al. Cerebral and ocular toxoplasmosis related with IFN-\u03b3, TNF-\u03b1, and IL-10 levels. Front. Microbiol. 5, 492 (2014).","journal-title":"Front. Microbiol."},{"key":"518_CR104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006176","volume":"13","author":"S Krishnamurthy","year":"2017","unstructured":"Krishnamurthy, S., Konstantinou, E. K., Young, L. H., Gold, D. A. & Saeij, J. P. The human immune response to Toxoplasma: autophagy versus cell death. PLoS Pathog. 13, e1006176 (2017).","journal-title":"PLoS Pathog."},{"key":"518_CR105","doi-asserted-by":"crossref","first-page":"e01157","DOI":"10.1128\/mBio.01157-15","volume":"6","author":"EM Selleck","year":"2015","unstructured":"Selleck, E. M. et al. A noncanonical autophagy pathway restricts Toxoplasma gondii growth in a strain-specific manner in IFN-\u03b3-activated human cells. mBio 6, e01157\u201315 (2015).","journal-title":"mBio"},{"key":"518_CR106","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006027","volume":"12","author":"B Clough","year":"2016","unstructured":"Clough, B. et al. K63-linked ubiquitination targets Toxoplasma gondii for endo-lysosomal destruction in IFN\u03b3-stimulated human cells. PLoS Pathog. 12, e1006027 (2016).","journal-title":"PLoS Pathog."},{"key":"518_CR107","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1189\/jlb.1008599","volume":"85","author":"SC Henry","year":"2009","unstructured":"Henry, S. C. et al. Balance of Irgm protein activities determines IFN-\u03b3-induced host defense. J Leukoc. Biol. 85, 877\u2013885 (2009).","journal-title":"J Leukoc. Biol."},{"key":"518_CR108","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nri3210","volume":"12","author":"JD MacMicking","year":"2012","unstructured":"MacMicking, J. D. Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat. Rev. Immunol. 12, 367\u2013382 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"518_CR109","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1172\/JCI28796","volume":"116","author":"RM Andrade","year":"2006","unstructured":"Andrade, R. M., Wessendarp, M., Gubbels, M. J., Striepen, B. & Subauste, C. S. CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes. J. Clin. Invest. 116, 2366\u20132377 (2006).","journal-title":"J. Clin. Invest."},{"key":"518_CR110","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1128\/IAI.01145-12","volume":"81","author":"J Van Grol","year":"2013","unstructured":"Van Grol, J., Muniz-Feliciano, L., Portillo, J. A., Bonilha, V. L. & Subauste, C. S. CD40 induces anti-Toxoplasma gondii activity in nonhematopoietic cells dependent on autophagy proteins. Infect. Immun. 81, 2002\u20132011 (2013).","journal-title":"Infect. Immun."},{"key":"518_CR111","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.4049\/jimmunol.162.11.6690","volume":"162","author":"CS Subauste","year":"1999","unstructured":"Subauste, C. S., Wessendarp, M., Sorensen, R. U. & Leiva, L. E. CD40\u2013CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer. J. Immunol. 162, 6690\u20136700 (1999).","journal-title":"J. Immunol."},{"key":"518_CR112","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.pt.2017.02.007","volume":"33","author":"B Clough","year":"2017","unstructured":"Clough, B. & Frickel, E. M. The Toxoplasma parasitophorous vacuole: an evolving host\u2013parasite frontier. Trends Parasitol. 33, 473\u2013488 (2017).","journal-title":"Trends Parasitol."},{"key":"518_CR113","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-065X.2010.00990.x","volume":"240","author":"LD Sibley","year":"2011","unstructured":"Sibley, L. D. Invasion and intracellular survival by protozoan parasites. Immunol. Rev. 240, 72\u201391 (2011).","journal-title":"Immunol. Rev."},{"key":"518_CR114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003809","volume":"9","author":"L Muniz-Feliciano","year":"2013","unstructured":"Muniz-Feliciano, L. et al. Toxoplasma gondii-induced activation of EGFR prevents autophagy protein-mediated killing of the parasite. PLoS Pathog. 9, e1003809 (2013).","journal-title":"PLoS Pathog."},{"key":"518_CR115","doi-asserted-by":"crossref","first-page":"34245","DOI":"10.1074\/jbc.M504158200","volume":"280","author":"PJ Bradley","year":"2005","unstructured":"Bradley, P. J. et al. Proteomic analysis of rhoptry organelles reveals many novel constituents for host\u2013parasite interactions in T. gondii. J. Biol. Chem. 280, 34245\u201334258 (2005).","journal-title":"J. Biol. Chem."},{"key":"518_CR116","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.mib.2019.07.002","volume":"52","author":"S Rastogi","year":"2019","unstructured":"Rastogi, S., Cygan, A. M. & Boothroyd, J. C. Translocation of effector proteins into host cells by Toxoplasma gondii. Curr Opin Microbiol 52, 130\u2013138 (2019).","journal-title":"Curr Opin Microbiol"},{"key":"518_CR117","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1462-5822.2009.01378.x","volume":"12","author":"MB Lodoen","year":"2010","unstructured":"Lodoen, M. B., Gerke, C. & Boothroyd, J. C. A highly sensitive FRET-based approach reveals secretion of the actin-binding protein toxofilin during Toxoplasma gondii infection. Cell. Microbiol. 12, 55\u201366 (2010).","journal-title":"Cell. Microbiol."},{"key":"518_CR118","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.chom.2019.09.008","volume":"26","author":"LO Sangare","year":"2019","unstructured":"Sangare, L. O. et al. In vivo CRISPR screen identifies TgWIP as a toxoplasma modulator of dendritic cell migration. Cell Host Microbe 26, 478\u2013492.e8 (2019).","journal-title":"Cell Host Microbe"},{"key":"518_CR119","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/microorganisms8060865","volume":"8","author":"PF Egea","year":"2020","unstructured":"Egea, P. F. Crossing the vacuolar rubicon: structural insights into effector protein trafficking in apicomplexan parasites. Microorganisms 8, 865 (2020).","journal-title":"Microorganisms"},{"key":"518_CR120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005434","volume":"11","author":"MS Behnke","year":"2015","unstructured":"Behnke, M. S. et al. Rhoptry proteins ROP5 and ROP18 are major murine virulence factors in genetically divergent South American strains of Toxoplasma gondii. PLoS Genet. 11, e1005434 (2015).","journal-title":"PLoS Genet."},{"key":"518_CR121","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1126\/science.1133643","volume":"314","author":"S Taylor","year":"2006","unstructured":"Taylor, S. et al. A secreted serine\u2013threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 314, 1776\u20131780 (2006).","journal-title":"Science"},{"key":"518_CR122","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1126\/science.1133690","volume":"314","author":"JPJ Saeij","year":"2006","unstructured":"Saeij, J. P. J. et al. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 314, 1780\u20131783 (2006).","journal-title":"Science"},{"key":"518_CR123","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1073\/pnas.1015980108","volume":"108","author":"ML Reese","year":"2011","unstructured":"Reese, M. L., Zeiner, G. M., Saeij, J. P., Boothroyd, J. C. & Boyle, J. P. Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence. Proc. Natl Acad. Sci. USA 108, 9625\u20139630 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"518_CR124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000576","volume":"8","author":"T Steinfeldt","year":"2010","unstructured":"Steinfeldt, T. et al. Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii. PLoS Biol. 8, e1000576 (2010).","journal-title":"PLoS Biol."},{"key":"518_CR125","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/cmi.12022","volume":"14","author":"SJ Fentress","year":"2012","unstructured":"Fentress, S. J. & Sibley, L. D. An arginine-rich domain of ROP18 is necessary for vacuole targeting and virulence in Toxopalsma gondii. Cell. Microbiol. 14, 1921\u20131933 (2012).","journal-title":"Cell. Microbiol."},{"key":"518_CR126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002992","volume":"8","author":"MS Behnke","year":"2012","unstructured":"Behnke, M. S. et al. The polymorphic pseudokinase ROP5 controls virulence in Toxoplasma gondii by regulating the active kinase ROP18. PLoS Pathog. 8, e1002992 (2012).","journal-title":"PLoS Pathog."},{"key":"518_CR127","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.chom.2014.04.002","volume":"15","author":"RD Etheridge","year":"2014","unstructured":"Etheridge, R. D., Alagan, A., Tang, K., Turk, B. E. & Sibley, L. D. ROP18 and ROP17 kinase complexes synergize to control acute virulence of Toxoplasma in the mouse. Cell Host Microbe 15, 537\u2013550 (2014).","journal-title":"Cell Host Microbe"},{"key":"518_CR128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002784","volume":"8","author":"W Niedelman","year":"2012","unstructured":"Niedelman, W. et al. The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-\u03b3 response. PLoS Pathog. 8, e1002784 (2012).","journal-title":"PLoS Pathog."},{"key":"518_CR129","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.parint.2013.10.012","volume":"63","author":"V Sanchez","year":"2014","unstructured":"Sanchez, V., de-la-Torre, A. & Gomez-Marin, J. E. Characterization of ROP18 alleles in human toxoplasmosis. Parasitol. Int. 63, 463\u2013469 (2014).","journal-title":"Parasitol. Int."},{"key":"518_CR130","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.chom.2011.04.015","volume":"9","author":"KD Jensen","year":"2011","unstructured":"Jensen, K. D. et al. Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammation. Cell Host Microbe 9, 472\u2013483 (2011).","journal-title":"Cell Host Microbe"},{"key":"518_CR131","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature05395","volume":"445","author":"JPJ Saeij","year":"2007","unstructured":"Saeij, J. P. J. et al. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 445, 324\u2013327 (2007).","journal-title":"Nature"},{"key":"518_CR132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002236","volume":"7","author":"BA Butcher","year":"2011","unstructured":"Butcher, B. A. et al. Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. PLoS Pathog. 7, e1002236 (2011).","journal-title":"PLoS Pathog."},{"key":"518_CR133","volume":"217","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. The Toxoplasma gondii virulence factor ROP16 acts in cis and trans, and suppresses T cell responses. J. Exp. Med. 217, e20181757 (2020).","journal-title":"J. Exp. Med."},{"key":"518_CR134","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3389\/fcimb.2019.00413","volume":"9","author":"A Hernandez-de-Los-Rios","year":"2019","unstructured":"Hernandez-de-Los-Rios, A. et al. Influence of two major Toxoplasma gondii virulence factors (ROP16 and ROP18) on the immune response of peripheral blood mononuclear cells to human toxoplasmosis infection. Front. Cell. Infect. Microbiol. 9, 413 (2019).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"518_CR135","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1084\/jem.20131272","volume":"211","author":"JS Ma","year":"2014","unstructured":"Ma, J. S. et al. Selective and strain-specific NFAT4 activation by the Toxoplasma gondii polymorphic dense granule protein GRA6. J. Exp. Med. 211, 2013\u20132032 (2014).","journal-title":"J. Exp. Med."},{"key":"518_CR136","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.20100717","volume":"208","author":"EE Rosowski","year":"2011","unstructured":"Rosowski, E. E. et al. Strain-specific activation of the NF-\u03baB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J. Exp. Med. 208, 195\u2013212 (2011).","journal-title":"J. Exp. Med."},{"key":"518_CR137","volume":"4","author":"L Gov","year":"2013","unstructured":"Gov, L., Karimzadeh, A., Ueno, N. & Lodoen, M. B. Human innate immunity to Toxoplasma gondii is mediated by host caspase-1 and ASC and parasite GRA15. mBio 4, e00255-13 (2013).","journal-title":"mBio"},{"key":"518_CR138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007923","volume":"15","author":"WJ Pandori","year":"2019","unstructured":"Pandori, W. J. et al. Toxoplasma gondii activates a Syk\u2013CARD9\u2013NF-\u03baB signaling axis and gasdermin D-independent release of IL-1\u03b2 during infection of primary human monocytes. PLoS Pathog. 15, e1007923 (2019).","journal-title":"PLoS Pathog."},{"key":"518_CR139","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-9-S2-S1","volume":"9","author":"AK Dunker","year":"2008","unstructured":"Dunker, A. K. et al. The unfoldomics decade: an update on intrinsically disordered proteins. BMC Genomics 9, S1 (2008).","journal-title":"BMC Genomics"},{"key":"518_CR140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008572","volume":"16","author":"HL Mercer","year":"2020","unstructured":"Mercer, H. L. et al. Toxoplasma gondii dense granule protein GRA24 drives MyD88-independent p38 MAPK activation, IL-12 production and induction of protective immunity. PLoS Pathog. 16, e1008572 (2020).","journal-title":"PLoS Pathog."},{"key":"518_CR141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008586","volume":"16","author":"D Mukhopadhyay","year":"2020","unstructured":"Mukhopadhyay, D., Arranz-Solis, D. & Saeij, J. P. J. Toxoplasma GRA15 and GRA24 are important activators of the host innate immune response in the absence of TLR11. PLoS Pathog. 16, e1008586 (2020).","journal-title":"PLoS Pathog."},{"key":"518_CR142","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.chom.2013.03.002","volume":"13","author":"A Bougdour","year":"2013","unstructured":"Bougdour, A. et al. Host cell subversion by Toxoplasma GRA16, an exported dense granule protein that targets the host cell nucleus and alters gene expression. Cell Host Microbe 13, 489\u2013500 (2013).","journal-title":"Cell Host Microbe"},{"key":"518_CR143","volume":"7","author":"H He","year":"2018","unstructured":"He, H. et al. Characterization of a Toxoplasma effector uncovers an alternative GSK3\/\u03b2-catenin-regulatory pathway of inflammation. eLife 7, e39887 (2018).","journal-title":"eLife"},{"key":"518_CR144","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41564-019-0431-8","volume":"4","author":"L Braun","year":"2019","unstructured":"Braun, L. et al. The Toxoplasma effector TEEGR promotes parasite persistence by modulating NF-\u03baB signalling via EZH2. Nat. Microbiol. 4, 1208\u20131220 (2019).","journal-title":"Nat. Microbiol."},{"key":"518_CR145","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00674-19","volume":"10","author":"MW Panas","year":"2019","unstructured":"Panas, M. W., Naor, A., Cygan, A. M. & Boothroyd, J. C. Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1. mBio 10, e00674-19 (2019).","journal-title":"mBio"},{"key":"518_CR146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002483","volume":"8","author":"C Lang","year":"2012","unstructured":"Lang, C. et al. Impaired chromatin remodelling at STAT1-regulated promoters leads to global unresponsiveness of Toxoplasma gondii-infected macrophages to IFN-\u03b3. PLoS Pathog. 8, e1002483 (2012).","journal-title":"PLoS Pathog."},{"key":"518_CR147","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.4049\/jimmunol.178.8.5154","volume":"178","author":"SK Kim","year":"2007","unstructured":"Kim, S. K., Fouts, A. E. & Boothroyd, J. C. Toxoplasma gondii dysregulates IFN-\u03b3 inducible gene expression in human fibroblasts: insights from a genome-wide transcriptional profiling. J. Immunol. 178, 5154\u20135165 (2007).","journal-title":"J. Immunol."},{"key":"518_CR148","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1084\/jem.20160340","volume":"213","author":"G Gay","year":"2016","unstructured":"Gay, G. et al. Toxoplasma gondii TgIST co-opts host chromatin repressors dampening STAT1-dependent gene regulation and IFN-\u03b3-mediated host defenses. J. Exp. Med. 213, 1779\u20131798 (2016).","journal-title":"J. Exp. Med."},{"key":"518_CR149","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.chom.2016.06.006","volume":"20","author":"P Olias","year":"2016","unstructured":"Olias, P., Etheridge, R. D., Zhang, Y., Holtzman, M. J. & Sibley, L. D. Toxoplasma effector recruits the Mi-2\/NuRD complex to repress STAT1 transcription and block IFN-\u03b3-dependent gene expression. Cell Host Microbe 20, 72\u201382 (2016).","journal-title":"Cell Host Microbe"},{"key":"518_CR150","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00046-20","volume":"11","author":"J Mayoral","year":"2020","unstructured":"Mayoral, J., Shamamian, P. Jr. & Weiss, L. M. In vitro characterization of protein effector export in the bradyzoite stage of Toxoplasma gondii. mBio 11, e00046-20 (2020).","journal-title":"mBio"},{"key":"518_CR151","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","volume":"472","author":"JW Schoggins","year":"2011","unstructured":"Schoggins, J. W. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481\u2013485 (2011).","journal-title":"Nature"},{"key":"518_CR152","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-9-488","volume":"9","author":"T Hulsen","year":"2008","unstructured":"Hulsen, T., de Vlieg, J. & Alkema, W. BioVenn \u2014 a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics 9, 488 (2008).","journal-title":"BMC Genomics"},{"key":"518_CR153","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100926","volume":"38","author":"D Fisch","year":"2019","unstructured":"Fisch, D. et al. Human GBP1 is a microbe-specific gatekeeper of macrophage apoptosis and pyroptosis. EMBO J. 38, e100926 (2019).","journal-title":"EMBO J."},{"key":"518_CR154","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78, 785\u2013798 (2013).","journal-title":"Neuron"},{"key":"518_CR155","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nn.4534","volume":"20","author":"H Pandya","year":"2017","unstructured":"Pandya, H. et al. Differentiation of human and murine induced pluripotent stem cells to microglia-like cells. Nat. Neurosci. 20, 753\u2013759 (2017).","journal-title":"Nat. Neurosci."},{"key":"518_CR156","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.neuron.2017.03.042","volume":"94","author":"EM Abud","year":"2017","unstructured":"Abud, E. M. et al. iPSC-derived human microglia-like cells to study neurological diseases. Neuron 94, 278\u2013293.e9 (2017).","journal-title":"Neuron"},{"key":"518_CR157","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41593-018-0175-4","volume":"21","author":"J Park","year":"2018","unstructured":"Park, J. et al. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer\u2019s disease. Nat. Neurosci. 21, 941\u2013951 (2018).","journal-title":"Nat. Neurosci."},{"key":"518_CR158","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.micinf.2016.03.012","volume":"18","author":"N Tanaka","year":"2016","unstructured":"Tanaka, N., Ashour, D., Dratz, E. & Halonen, S. Use of human induced pluripotent stem cell-derived neurons as a model for cerebral toxoplasmosis. Microbes Infect. 18, 496\u2013504 (2016).","journal-title":"Microbes Infect."},{"key":"518_CR159","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuron.2019.07.014","volume":"104","author":"R Tian","year":"2019","unstructured":"Tian, R. et al. CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons. Neuron 104, 239\u2013255.e12 (2019).","journal-title":"Neuron"},{"key":"518_CR160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","volume":"132","author":"B Levine","year":"2008","unstructured":"Levine, B. & Kroemer, G. Autophagy in the pathogenesis of disease. Cell 132, 27\u201342 (2008).","journal-title":"Cell"},{"key":"518_CR161","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2014.05.006","volume":"40","author":"J Choi","year":"2014","unstructured":"Choi, J. et al. The parasitophorous vacuole membrane of Toxoplasma gondii is targeted for disruption by ubiquitin-like conugation systems of autophagy. Immunity 40, 924\u2013935 (2014).","journal-title":"Immunity"},{"key":"518_CR162","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.chom.2008.10.003","volume":"4","author":"Z Zhao","year":"2008","unstructured":"Zhao, Z. et al. Autophagosome-independent essential function for the autophagy protein Atg5 in cellular immunity to intracellular pathogens. Cell Host Microbe 4, 458\u2013469 (2008).","journal-title":"Cell Host Microbe"},{"key":"518_CR163","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.4049\/jimmunol.1302822","volume":"192","author":"J Ohshima","year":"2014","unstructured":"Ohshima, J. et al. Role of mouse and human autophagy proteins in IFN-\u03b3-induced cell-autonomous responses against Toxoplasma gondii. J. Immunol. 192, 3328\u20133335 (2014).","journal-title":"J. Immunol."},{"key":"518_CR164","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrmicro3160","volume":"12","author":"J Huang","year":"2014","unstructured":"Huang, J. & Brumell, J. H. Bacteria\u2013autophagy interplay: a battle for survival. Nat. Rev. Microbiol. 12, 101\u2013114 (2014).","journal-title":"Nat. Rev. Microbiol."},{"key":"518_CR165","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.mib.2011.07.002","volume":"14","author":"JC Howard","year":"2011","unstructured":"Howard, J. C., Hunn, J. P. & Steinfeldt, T. The IRG protein-based resistance mechanism in mice and its relation to virulence in Toxoplasma gondii. Curr. Opin. Microbiol. 14, 414\u2013421 (2011).","journal-title":"Curr. Opin. Microbiol."},{"key":"518_CR166","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1462-5822.2010.01443.x","volume":"12","author":"A Khaminets","year":"2010","unstructured":"Khaminets, A. et al. Coordinated loading of IRG resistance GTPases on to the Toxoplasma gondii parasitophorous vacuole. Cell. Microbiol. 12, 939\u2013961 (2010).","journal-title":"Cell. Microbiol."},{"key":"518_CR167","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003414","volume":"9","author":"AK Haldar","year":"2013","unstructured":"Haldar, A. K. et al. IRG and GBP host resistance factors target aberrant, \u201cnon-self\u201d vacuoles characterized by the missing of \u201cself\u201d IRGM proteins. PLoS Pathog. 9, e1003414 (2013).","journal-title":"PLoS Pathog."},{"key":"518_CR168","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01298","volume":"2","author":"J Lilue","year":"2013","unstructured":"Lilue, J., Muller, U. B., Steinfeldt, T. & Howard, J. C. Reciprocal virulence and resistance polymorphism in the relationship between Toxoplasma gondii and the house mouse. eLife 2, e01298 (2013).","journal-title":"eLife"},{"key":"518_CR169","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2005-6-11-r92","volume":"6","author":"C Bekpen","year":"2005","unstructured":"Bekpen, C. et al. The interferon-inducible p47 (IRG) GTPases in vertebrates: loss of the cell autonomous resistance mechanism in the human lineage. Genome Biol. 6, R92 (2005).","journal-title":"Genome Biol."},{"key":"518_CR170","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.chom.2012.09.007","volume":"12","author":"BH Kim","year":"2012","unstructured":"Kim, B. H., Shenoy, A. R., Kumar, P., Bradfield, C. J. & MacMicking, J. D. IFN-inducible GTPases in host cell defense. Cell Host Microbe 12, 432\u2013444 (2012).","journal-title":"Cell Host Microbe"},{"key":"518_CR171","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.immuni.2012.06.009","volume":"37","author":"M Yamamoto","year":"2012","unstructured":"Yamamoto, M. et al. A cluster of Interferon-\u03b3-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii. Immunity 37, 302\u2013313 (2012).","journal-title":"Immunity"},{"key":"518_CR172","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003320","volume":"9","author":"EM Selleck","year":"2013","unstructured":"Selleck, E. M. et al. Guanylate-binding protein 1 (Gbp1) contributes to cell-autonomous immunity against Toxoplasma gondii. PLoS Pathog. 9, e1003320 (2013).","journal-title":"PLoS Pathog."},{"key":"518_CR173","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1073\/pnas.1205635110","volume":"110","author":"D Degrandi","year":"2013","unstructured":"Degrandi, D. et al. Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication. Proc. Natl Acad. Sci. USA 110, 294\u2013299 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"518_CR174","doi-asserted-by":"crossref","first-page":"27452","DOI":"10.1074\/jbc.M112.379636","volume":"287","author":"E Kravets","year":"2012","unstructured":"Kravets, E. et al. The GTPase activity of murine guanylate-binding protein 2 (mGBP2) controls the intracellular localization and recruitment to the parasitophorous vacuole of Toxoplasma gondii. J. Biol. Chem. 287, 27452\u201327466 (2012).","journal-title":"J. Biol. Chem."},{"key":"518_CR175","doi-asserted-by":"crossref","first-page":"02993-19","DOI":"10.1128\/mBio.02993-19","volume":"11","author":"N Steffens","year":"2020","unstructured":"Steffens, N. et al. Essential role of mGBP7 for survival of Toxoplasma gondii infection. mBio 11, 02993-19 (2020).","journal-title":"mBio"},{"key":"518_CR176","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.11479","volume":"5","author":"E Kravets","year":"2016","unstructured":"Kravets, E. et al. Guanylate binding proteins directly attack Toxoplasma gondii via supramolecular complexes. eLife 5, e11479 (2016).","journal-title":"eLife"},{"key":"518_CR177","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01393-18","volume":"9","author":"SK Matta","year":"2018","unstructured":"Matta, S. K. et al. NADPH oxidase and guanylate binding protein 5 restrict survival of avirulent type III strains of Toxoplasma gondii in naive macrophages. mBio 9, e01393-18 (2018).","journal-title":"mBio"},{"key":"518_CR178","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1073\/pnas.1619665114","volume":"114","author":"A Qin","year":"2017","unstructured":"Qin, A. et al. Guanylate-binding protein 1 (GBP1) contributes to the immunity of human mesenchymal stromal cells against Toxoplasma gondii. Proc. Natl Acad. Sci. USA 114, 1365\u20131370 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"518_CR179","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/cmi.12579","volume":"18","author":"AC Johnston","year":"2016","unstructured":"Johnston, A. C. et al. Human GBP1 does not localize to pathogen vacuoles but restricts Toxoplasma gondii. Cell. Microbiol. 18, 1056\u20131064 (2016).","journal-title":"Cell. Microbiol."}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41579-021-00518-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41579-021-00518-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41579-021-00518-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T17:35:48Z","timestamp":1697909748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41579-021-00518-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":179,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["518"],"URL":"https:\/\/doi.org\/10.1038\/s41579-021-00518-7","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]},"assertion":[{"value":"19 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}